technology

  • Laser Doppler
  • Velocimetry
  • Flowmetry

devices

news & scientifique publications

  • News
  • Technology
  • Medical Studies

Y-YBAR is producing medical devices for the research in ophthalmolgy. these devices -based on laser doppler flowmetry- measure relative choroidal blood flow. if you are conducting research in vascular system of the eye, for example in the case of glaucoma, if you need an objective criterion to measure the effect of your vascular treatment, if you want to know the effect of your drug on choroidal blood flow then our devices are for you.

Agreement for the development of a new choroidal blood flowmeter device


SynCoreBio signed Co-operation and Development Agreement of New Choroidal Blood Flowmeter with Y-YBar Swiss.

SynCoreBio is currently conducting a Phase II / III trial of Dry AMD, an Asia trial authorized by MacuCLEAR (USA) by using an identical ophthalmic diagnostic instrument as MacuCLEAR. This device, FloM-S, measures choroidal blood perfusion changes and is based on the principle of Laser Doppler Flowmetry (LDF). This technology, first proposed by Charles Riva, has already been used for many clinical studies ranging from microgravity (NASA) to high altitude (6000 m a.M), during cardiac surgery or more commonly during gas respiration.

According to WHO, "There is 285 million people in the world is suffering from a vision loss, 39 million are blind and 246 million have poor eyesight." The major cause of blindness are: cataracts (39%), refractive errors (18%), glaucoma (10%) and Dry-AMD (7%) (WHO's 2009 survey). By measuring the changes of fundus blood flow, those diseases could be early detected.

According to the BMI Espicom database, global medical device market is growing steadily, marked up to 4,053 billion US dollars in 2017, and the number of patients with chronic eye diseases will only increase year by year. Considering the future need for ophthalmology diagnosis, SynCore started the ophthalmic diagnosis instrument department in 2013. In 2016, Syncore and Y-Ybar signed an agreement to definitively improve the development of ophthalmic medical device industry, to provide early prevention and treatment of eye diseases in humans.

November 8th 2016


Références web:
SynCoreBio: http://www.syncorebio.com
Macuclear: http://macuclear.com
WHO's 2009 survey: http://who.int